Today, pouch disorders are no longer lumped together in one diagnostic bucket. Understanding which of 5 types of pouch disorders your patient has is key to providing the best possible therapy.
Discover how your patients with gastroparesis can benefit from Cleveland Clinic’s new gastroparesis clinic, which unites experts in gastroenterology, general surgery and others in one, unique setting.
Celiac disease is more than twice as common in people with cirrhosis of the liver than in the general population, a new study says — indicating that routine screening for Celiac disease may be warranted for these patients.
Physicians in the Digestive Disease Institute’s Endoscopy Section are optimizing patient care through use of several new technologies.
First, they are evaluating Hemospray powder (Cook Medical, Winston-Salem, N.C.) to control diffuse gastrointestinal bleeding.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The Intensive Review of Gastroenterology & Hepatology (a boot camp for GI boards), happening August 23-26, 2014 at Loews Coronado Bay in San Diego, CA, is a course that provides an intensive review of gastroenterology and hepatology through the lens of successful test-taking. It is targeted for candidates preparing for both initial certification and maintenance of re-certification AND for those in clinical practice who need a high-paced intensive review of the field. To meet the high standards required to pass the boards, we have put together this intensive review course which brings outstanding teachers from Cleveland Clinic and other leading institutions.
Exhaled breath analysis shows promise for noninvasive diagnosis
Jeffrey Ponsky, MD, has rejoined Cleveland Clinic in a newly created role focused on his passion for hands-on clinical innovations. Hear his thoughts on what’s next in minimally invasive surgery.
FMT is a ground-breaking treatment for diarrhea caused by Clostridium difficile bacteria. By transferring “healthy” bacteria from a donor into a patient’s intestines, it’s hoped the proper balance of bacteria will be restored.